Study On The Involvement Of Wif-1 In Oral Carcinogenesis Via Egfr And Wnt Signaling Pathways

Simple item page
dc.contributor.authorTAN WEI, CHOW
dc.date.accessioned2016-05-10T06:58:37Z
dc.date.available2016-05-10T06:58:37Z
dc.date.issued2015-08
dc.description.abstractWNT inhibitory factor 1 (WIF-1) is a physiological inhibitor in WNT signaling pathway via its WIF domain. The function of EGF-like domain in WIF-1 remains unclear. Recent studies had indicated an increase in WIF-1 expression in progressive cancer cells, a phenomenon contradicting to the known cell signaling mechanisms in cancer cell progression. The present study aimed at elucidating the potential binding of WIF-1 to EGFR, leading to initiation of EGFR downstream signaling cascades and/or via the crosstalk between EGFR and downstream of WNT signaling pathways, which ultimately resulting in cancer formation. Initial protein-protein docking between WIF-1 and EGFR molecules was performed using CAPRI-listed online servers, namely ZDOCK, GRAMM-X, HEX and PatchDock. Co-immunoprecipitation and Western blot were designed to study the binding of EGFR/WIF-1 and the potential activation of EGFR and WNT downstream signaling pathways resulting upon the binding. Stable mutant cell lines were established to study the crosstalk between WNT and EGFR signaling pathways. Downstream gene expression initiated by the crosstalk was investigated using quantitative real-time PCR. The experimental results suggested that WIF-1 could play additional role in EGFR signaling pathway via its EGF-like domain. In silico binding of WIF-1 to EGFR was energetically favorable (-616.40 kcal/mol), as compared to EGF/EGFR binding (-627.18 kcal/mol). In co-immunoprecipitation, WIF-1 was bound to, and hence was co-immunoprecipitated with, EGFR. Downstream key factors in EGFR signaling pathway were found to be activated following the binding of WIF-1 to EGFR. Moreover, the results obtained showed a prominent activation of downstream, but not of upstream, cascades of WNT signaling pathway via crosstalk from WIF-1 activated EGFR signaling pathway. In short, the data obtained have clearly shown that WIF-1 might play a different role in cancer formation by interacting with EGFR, rather than acting as an antagonist of WNT members. It is therefore crucial to review the appropriateness of WIF-1 to be used as an anti-cancer agent in the field.en_US
dc.identifier.urihttp://hdl.handle.net/123456789/2005
dc.subjectStudy On The Involvement Of Wif-1 In Oral Carcinogenesisen_US
dc.subjectVia Egfr And Wnt Signaling Pathwaysen_US
dc.titleStudy On The Involvement Of Wif-1 In Oral Carcinogenesis Via Egfr And Wnt Signaling Pathwaysen_US
dc.typeThesisen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Chow Tan Wei_Study on the involvement of WIF-1 in oral carcinogenesis via EGFR an_20150824172133169.pdf
Size:
6.88 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Tidak Diketahui Pusat Pengajian - Tesis